Edition:
United States

People: GenVec Inc (GNVC.OQ)

GNVC.OQ on NASDAQ Stock Exchange Capital Market

3.02USD
2 Dec 2016
Change (% chg)

$-0.13 (-4.13%)
Prev Close
$3.15
Open
$3.03
Day's High
$4.65
Day's Low
$3.00
Volume
123,009
Avg. Vol
3,437
52-wk High
$36.90
52-wk Low
$2.70

Swirsky, Douglas 

Mr. Douglas J. Swirsky is President, Chief Executive Officer, Corporate Secretary, Director of GenVec, Inc. He joined GenVec in 2006 as Chief Financial Officer, Treasurer, and Corporate Secretary; and continues to serve as Corporate Secretary. Prior to joining GenVec, Mr. Swirsky was a Managing Director and the Head of Life Sciences Investment Banking at Stifel Nicolaus from 2005 to 2006 and held investment banking positions at Legg Mason from 2002 until Stifel Financial’s acquisition of the Legg Mason Capital Markets business in 2005. Mr. Swirsky, a Certified Public Accountant and a holder of a Chartered Financial Analyst® designation, has also previously held investment banking positions at UBS, PaineWebber, and Morgan Stanley. His experience also includes positions in public accounting and consulting. Mr. Swirsky received his B.S. in Business Administration from Boston University and his M.B.A. from the Kellogg School of Management at Northwestern University. Mr. Swirsky is a member of the Board of Directors of Fibrocell Science, Inc. Within the past five years, Mr. Swirsky has also served on the board of PolyMedix, Inc.

Basic Compensation

Total Annual Compensation, USD 375,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 380,024
Fiscal Year Total, USD 755,024

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --